Middle East and Africa Eye Health Supplement Market to Grow at a CAGR of 4.4% to reach US$ 145.60 Million from 2020 to 2027

Middle East and Africa Eye Health Supplement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Ingredient type (Lutein and Zeaxanthin, Antioxidants, Omega-3 fatty acids, Coenzyme Q10, Flavonoids, Astaxanthin, Alpha-Lipoic acid, Others); Indication (Age-related macular degeneration (AMD), Cataract, Dry eye syndrome, Others); and Form (Tablet, Capsule, Drops), and Countries

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027
  • Report Date : Nov 2020
  • Report Code : TIPRE00015870
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 144
Buy Now  
Middle East and Africa Eye Health Supplement Market to Grow at a CAGR of 4.4% to reach US$ 145.60 Million from 2020 to 2027
Report Date: Nov 2020   |   Report Code: TIPRE00015870
Buy Now
Page Updated: Feb 2021

The Middle East and Africa Eye Health Supplement market is expected to reach US$ 145.60 million by 2027 from US$ 104.34 million in 2019; it is anticipated to grow at a CAGR of 4.4% during 2019–2027.



The key factors driving the market growth are increasing emphasis preventive care, considerable rise in eye diseases, and aging population. In addition, growing adoption dietary supplements and nutritional products is also expected to drive the market growth by 2027. However, high costs associated to Eye Health Supplement and limited availability of product in Middle East and Africa Eye Health Supplement market is the major factor hindering the market growth in Middle East and Africa. 

Eye supplements are nutritional products which care recommended to maintain eye health and good vision. The eye health supplements prominently comprises vitamin A, lutein & Zeaxanthin, omega 3 fatty acids, gamma-linoleic acid, and others. These nutritional supplements helps to sustain eye function, reduce the development of age-related eye diseases, and protect eyes against harmful light. Eye health supplements can be useful over range of eye diseases such as dry eye, age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts amongst others. Increasing prevalence of eye diseases coupled with aging population is likely to drive the growth of the eye health supplement market during the forecast period.

Growing prevalence of eye disorders and abnormalities is anticipated to drive the adoption of eye health supplements, which would eventually drive the eye health supplements market during the forecast period. For instance, according to the study in 2019, “Prevalence and Determinants of Dry Eye Disease among 40 Years and Older Population”, published by the Middle East African Journal of Ophthalmology, the prevalence of dry eye syndrom, was 35%. In addition, the prevalence of blindness among the population aged 50 years and older in Saudi Arabia was 3.3%, prevalence of glaucoma was 5.8%  according to study reported by Middle East Journal of Family Medicines in December 2019. Cataract is the major cause of blindness in more than 50% population and more than 20% of visual impairment cases were due to age related eye diseases.

Herbalife Nutrition Ltd., Alcon Inc., Bausch Health Companies Inc. are among the major companies in Eye Health Supplement market.

COVID-19 pandemic has become the most significant challenge across the Middle East and Africa region. This challenge will be frightening the countries across the region as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of eye health supplements, resulting in a considerable price increase. Manufacturers are also experiencing raised prices and potential shortages of raw ingredients due to supply restrictions.

South Africa Eye Health Supplement Market, Revenue and Forecast to 2027 (US$ Mn)

South Africa Eye Health Supplement Market, Revenue and Forecast to 2027 (US$ Mn)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MIDDLE EAST AND AFRICA EYE HEALTH SUPPLEMENT MARKET SEGMENTATION

MIDDLE EAST AND AFRICA EYE HEALTH SUPPLEMENT MARKET SEGMENTATION


By Ingredient Type

  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 fatty acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic acid
  • Others


By Indication

  • Age-related macular degeneration (AMD)
  • Cataract
  • Dry eye syndrome
  • Others


By Forms

  • Tablet
  • Capsule
  • Drops


By Country

  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of the Middle East and Africa


Company Profiles

  • Nordic Naturals
  • Herbalife Nutrition Ltd.
  • The Nature's Bounty Co
  • AMWAY
  • Pfizer Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Alliance Pharma PLC
  • Allergan Plc.

Middle East and Africa Eye Health Supplement Report Scope

Report Attribute Details
Market size in 2019 US$ 104.34 Million
Market Size by 2027 US$ 145.60 Million
CAGR (2019 - 2027) 4.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Ingredient Type
  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 fatty acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic acid
  • Others
By Indication
  • Age-related macular degeneration
  • Cataract
  • Dry eye syndrome
By Form
  • Tablet
  • Capsule
  • Drops
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Nordic Naturals
  • Herbalife Nutrition Ltd.
  • The Nature's Bounty Co
  • AMWAY
  • Pfizer Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Alliance Pharma PLC
  • Allergan Plc.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA